世界の動物成長促進剤・運動能力増強剤（パフォーマンス・エンハンサー）市場は、2021年の162億ドルから2026年までに214億ドルに達し、CAGRは5.7％と予想されます。成長促進剤や運動能力増強剤を含む動物医療製品は、動物の成長に使用される医薬品や化学薬品の一種です。これらの増強・促進剤は食物をより効果的に消化し、動物がより速く成長することを可能にし、それが生産性の向上につながります。この市場の成長を促す主な要因としては、動物の消費および家畜を用いた製品の需要の増加、自然に生産された成長促進剤に対する世界的な需要の高まり、および動物の疫病の増加、気候変動の問題などが挙げられます。一方で、さまざまな国での抗生物質の禁止と動物の成長促進のための抗生物質とホルモンの使用を制限する厳しい規制が、予測期間中におけるこの市場の成長を抑制する可能性があります。
American Veterinary Medical Association（AVMA）によると、動物がヒトCOVID-19感染の拡大に重要な疫学的役割を果たしているという証拠はありません。ただし、動物と人間は互いに感染する可能性があるため、感染が疑われる/確認された人は動物との接触を防ぎ、ペットや動物を扱う際には注意を払うことが推奨されました。COVID-19の影響を評価し、市場予測を行うために、シナリオを基にした方法が検討されています。
市場の主要なプレーヤーは、これらの混乱に対処するために対策を講じています。たとえば、2020年4月、Merck＆Co。、Inc。は、動物用医薬品セグメントへの悪影響を見越して、2020年の収益予想を約25億ドル引き下げることを発表しました。動物用医薬品の製造能力と生産量の減少は、製品の不足やサプライチェーンの混乱を生み、2020年から2021年の市場成長率にマイナスの影響を及ぼしました。
2020年の第2四半期に、動物用医薬品から得られる収益は大幅に減少しました。たとえば、動物用医薬品事業のリーダーであるElanco Animal Health Incorporated（US）は、主に臨床的に投与される医薬品における家畜用動物事業の需要の減少によって、第2四半期には32.4％減少しました。この減少は、成長促進剤のバリューチェーン全体で獣医の訪問数の減少と運転資本の増加につながります。ただし、バイエルの動物用医薬品セグメントの買収により、2020年の第3四半期から収益曲線にプラスのシフトがもたらされ、COVID-19によるマイナスの影響が正常化されました。対照的に、Cargill、Incorporated（US）、Merck and Co.、Inc。（US）、Zoetis（US）など、動物用医薬品の他の主要メーカーは、COVID-19による収益がマイナス成長にはなりませんでした。COVID-19のパンデミックによって引き起こされたサプライチェーンの混乱により、主要メーカーは短期的に海外から国内サプライヤーに移行する可能性があります。さらに、さまざまな地域の取引条件に基づいて長期間利用できない場合、製造業者が伝統的に使用してきた原材料の供給源が変化する可能性があります。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 26)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SEGMENTATION
FIGURE 2 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 33)
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: ROYAL DSM N.V.
FIGURE 9 SUPPLY SIDE MARKET SIZE ESTIMATION: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2021-2026): IMPACT ON MARKET GROWTH & CAGR
FIGURE 11 CAGR PROJECTIONS
FIGURE 12 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
3 EXECUTIVE SUMMARY (Page No. - 47)
FIGURE 14 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
4 PREMIUM INSIGHTS (Page No. - 50)
4.1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET OVERVIEW
FIGURE 18 CONTINUOUS GROWTH IN THE GLOBAL MEAT DEMAND TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (2020)
FIGURE 19 NON-ANTIBIOTIC GROWTH PROMOTERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
FIGURE 20 EUROPEAN COUNTRIES TO WITNESS HIGH CAGR DURING THE FORECAST PERIOD
4.4 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: REGIONAL MIX
FIGURE 21 ASIA PACIFIC IS THE LARGEST MARKET FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
5 MARKET OVERVIEW (Page No. - 54)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increase in demand and consumption of livestock-based products
TABLE 2 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS
FIGURE 23 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 24 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
5.2.1.2 Research for alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters
5.2.1.3 Rise in the global demand for naturally produced growth promoters
5.2.1.4 Rise in awareness about growth promoters
FIGURE 25 US: ANTIBIOTICS SALES (2018)
5.2.1.5 Rise in animal epidemics and climate change
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals
5.2.2.2 Ban on antibiotics in different nations
TABLE 3 BANS ON ANTIBIOTICS AND HORMONES, BY COUNTRY AND YEAR
5.2.3 OPPORTUNITIES
5.2.3.1 Focus on increasing environmental sustainability
5.2.4 CHALLENGES
5.2.4.1 Increasing global feed tonnage and high feed costs leading to the adoption of conventional feeding systems
5.2.4.2 Growing threat of disease transmission to and from agricultural animals
6 INDUSTRY INSIGHTS (Page No. - 64)
6.1 INDUSTRY TRENDS
6.1.1 INVESTMENT TOWARDS NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 4 INVESTMENT TOWARDS ANIMAL GROWTH PROMOTERS
6.1.2 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY
TABLE 5 MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY (2017-2019)
6.2 PRICING ANALYSIS
TABLE 6 AVERAGE SELLING PRICE OF ANIMAL GROWTH PROMOTERS
TABLE 7 SIMULATION OF THE ECONOMIC IMPACT OF REMOVING ANTIBIOTIC GROWTH PROMOTERS (AGP)
6.3 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.4 ECOSYSTEM MAPPING
FIGURE 27 ECOSYSTEM ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.5 SUPPLY CHAIN ANALYSIS
FIGURE 28 SUPPLY CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
6.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 PORTERS FIVE FORCES ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)
6.6.1 INTENSITY OF COMPETITIVE RIVALRY
6.6.2 BARGAINING POWER OF SUPPLIERS
6.6.3 BARGAINING POWER OF BUYERS
6.6.4 THREAT OF NEW ENTRANTS
6.6.5 THREAT OF SUBSTITUTES
6.7 REGULATORY ANALYSIS
FIGURE 29 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
FIGURE 30 APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS IN EUROPE
6.8 PATENT ANALYSIS
6.8.1 PATENT PUBLICATION TRENDS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
FIGURE 31 GLOBAL PATENT PUBLICATION TRENDS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, 2015-2020
6.9 TRADE ANALYSIS
TABLE 9 IMPORT SHIPMENT RELATED TO ANIMAL GROWTH PROMOTERS
6.10 IMPACT OF THE COVID-19 PANDEMIC ON THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (Page No. - 79)
7.1 INTRODUCTION
TABLE 10 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
7.2 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 11 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 12 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.2.1 PREBIOTICS & PROBIOTICS
7.2.1.1 Prebiotics & probiotics hold the largest share of the market
TABLE 13 PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.2.2 ACIDIFIERS
7.2.2.1 Regulations on antibiotics and wide applications in different production animals to drive the use of acidifiers
TABLE 14 ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.2.3 PHYTOGENICS
7.2.3.1 Natural performance enhancement and antioxidative & disease defense properties to support the use of phytogenics
TABLE 15 PHYTOGENICS GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.2.4 FEED ENZYMES
7.2.4.1 Feed enzymes segment to benefit from the bans on antibiotics and hormones
TABLE 16 FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.2.5 HORMONES
7.2.5.1 Human health implications and restricted usage due to regulations to hamper the growth of the hormones segment
TABLE 17 HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.2.6 OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 18 OTHER NON-ANTIBIOTIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.3 ANTIBIOTIC GROWTH PROMOTERS
7.3.1 ANTIBIOTIC GROWTH PROMOTERS TO FACE A GRADUAL DECLINE DUE TO UNFAVORABLE REGULATIONS AND BANS
TABLE 19 PERCENTAGE SALES OF ANTIMICROBIAL SUBSTANCES IN THE US (2019)
TABLE 20 ANTIBIOTICS BANS AND REGULATIONS, BY COUNTRY
TABLE 21 ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE (Page No. - 93)
8.1 INTRODUCTION
TABLE 22 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
8.2 POULTRY
8.2.1 THE POULTRY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2020
TABLE 23 IMPORTANT STATISTICS RELATED TO POULTRY MEAT (2020)
TABLE 24 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR POULTRY, BY COUNTRY, 2019-2026 (USD MILLION)
8.3 LIVESTOCK
8.3.1 THE LIVESTOCK SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
TABLE 25 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR LIVESTOCK, BY COUNTRY, 2019-2026 (USD MILLION)
8.4 SWINE
8.4.1 RISING DEMAND FOR PORK MEAT AND THE INCREASING AWARENESS OF AFRICAN SWINE FEVER (ASF) OUTBREAK TO DRIVE THE ADOPTION OF GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
TABLE 26 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR SWINE, BY COUNTRY, 2019-2026 (USD MILLION)
8.5 AQUATIC ANIMALS
8.5.1 GROWING PRODUCTION AND CONSUMPTION OF SEAFOOD TO DRIVE THE DEMAND FOR GROWTH PROMOTERS
TABLE 27 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2019-2026 (USD MILLION)
8.6 OTHER ANIMALS
TABLE 28 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2019-2026 (USD MILLION)
9 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION (Page No. - 102)
9.1 INTRODUCTION
FIGURE 32 ASIA PACIFIC WILL DOMINATE THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET DURING THE FORECAST PERIOD
TABLE 29 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2019-2026 (USD MILLION)
9.2 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT
TABLE 30 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 31 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 32 ASIA PACIFIC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 33 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.2.1 CHINA
9.2.1.1 China to dominate the APAC animal growth promoters and performance enhancers market
TABLE 34 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 35 CHINA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 36 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.2.2 INDIA
9.2.2.1 Large livestock population and increased production and export capacities to drive market growth
TABLE 37 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 38 INDIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 39 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.2.3 JAPAN
9.2.3.1 Rising domestic meat demand and government efforts to encourage animal producers to drive the demand for growth promoters in Japan
TABLE 40 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 41 JAPAN: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 42 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.2.4 AUSTRALIA
9.2.4.1 Large cattle population and heavy meat exports to support the market in Australia
TABLE 43 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 44 AUSTRALIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 45 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.2.5 REST OF ASIA PACIFIC
9.2.5.1 Lack of a defined regulatory scenario to result in the wide use of antibiotic growth promoters in the RoAPAC
TABLE 46 REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY
TABLE 47 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 48 ROAPAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 49 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.3 NORTH AMERICA
TABLE 50 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 51 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 52 NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 53 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.3.1 US
9.3.1.1 Increasing meat consumption to drive the market in the US
FIGURE 34 US: GROWTH IN BEEF CONSUMPTION, 2014-2019 (BILLION POUNDS)
TABLE 54 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 55 US: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 56 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.3.2 CANADA
9.3.2.1 Production and export of meat and aquaculture in Canada to drive the market growth
TABLE 57 BEEF AND VEAL EXPORTS BY CANADA BETWEEN OCTOBER 2018 AND OCTOBER 2019
TABLE 58 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 59 CANADA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 60 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.4 EUROPE
FIGURE 35 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT
TABLE 61 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 62 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 63 EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 64 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.4.1 UK
9.4.1.1 Preventive measures to avoid the risk of zoonotic diseases to drive the market in the UK
TABLE 65 UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 66 UK: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 67 UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.4.2 GERMANY
9.4.2.1 Increasing veterinary visits and growing healthcare expenditure to boost the growth of the market in Germany
FIGURE 36 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011 TO 2018)
TABLE 68 GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 69 GERMANY: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 70 GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.4.3 SWITZERLAND
9.4.3.1 Increasing milk demand to drive the market in Switzerland
TABLE 71 SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 72 SWITZERLAND: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 73 SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.4.4 RUSSIA
9.4.4.1 Russia to hold the largest share of the European market due to its large poultry production
TABLE 74 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 75 RUSSIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 76 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.4.5 REST OF EUROPE
9.4.5.1 Technological advancements and the strong trade industry to support the RoE market
TABLE 77 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 78 ROE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 79 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 80 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 81 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 82 LATIN AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 83 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil to dominate the Latin American market for animal growth promoters and performance enhancers
TABLE 84 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 85 BRAZIL: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 86 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.5.2 REST OF LATIN AMERICA
9.5.2.1 Strong demand for animal products and support initiatives to help the market in the RoLA
TABLE 87 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 88 ROLA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 89 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.6 MIDDLE EAST
9.6.1 INCREASING DEMAND FOR CHICKEN AND SEAFOOD TO CONTRIBUTE TO MARKET GROWTH IN THE MIDDLE EAST
TABLE 90 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 91 MIDDLE EAST: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 92 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
9.7 AFRICA
9.7.1 RELIANCE ON CONVENTIONAL LIVESTOCK PRODUCTION PRACTICES TO HAMPER THE MARKET GROWTH IN AFRICA
TABLE 93 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 94 AFRICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 95 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019-2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 144)
10.1 INTRODUCTION
FIGURE 37 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)
10.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
10.3 MARKET SHARE ANALYSIS
FIGURE 39 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2020
10.4 COMPETITIVE SCENARIO
10.4.1 PRODUCT LAUNCHES
TABLE 96 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: PRODUCT LAUNCHES (JANUARY 2018 TO AUGUST 2021)
10.4.2 DEALS
TABLE 97 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DEALS (JANUARY 2018 TO AUGUST 2021)
10.4.3 OTHER DEVELOPMENTS
TABLE 98 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)
10.5 COMPETITIVE BENCHMARKING
10.5.1 COMPANY FOOTPRINT FOR KEY PLAYERS
10.5.2 PRODUCT TYPE FOOTPRINT OF COMPANIES
10.5.3 ANIMAL TYPE FOOTPRINT OF COMPANIES
10.5.4 REGIONAL FOOTPRINT OF COMPANIES
10.6 GEOGRAPHIC FOOTPRINT OF COMPANIES
10.6.1 GEOGRAPHIC REVENUE MIX: KEY PLAYERS
10.7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: R&D EXPENDITURE
10.7.1 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2019 VS. 2020)
10.8 COMPANY EVALUATION MATRIX
10.8.1 STARS
10.8.2 EMERGING LEADERS
10.8.3 PERVASIVE PLAYERS
10.8.4 EMERGING COMPANIES
FIGURE 40 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: GLOBAL COMPANY EVALUATION MATRIX
10.9 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
10.9.1 PROGRESSIVE COMPANIES
10.9.2 STARTING BLOCKS
10.9.3 RESPONSIVE COMPANIES
10.9.4 DYNAMIC COMPANIES
FIGURE 41 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS
11 COMPANY PROFILES (Page No. - 160)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 CARGILL, INCORPORATED
TABLE 99 CARGILL, INCORPORATED: BUSINESS OVERVIEW
11.1.2 ROYAL DSM N.V.
TABLE 100 ROYAL DSM N.V.: BUSINESS OVERVIEW
FIGURE 42 COMPANY SNAPSHOT: ROYAL DSM N.V. (2020)
11.1.3 ELANCO ANIMAL HEALTH INCORPORATED
TABLE 101 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW
FIGURE 43 COMPANY SNAPSHOT: ELANCO ANIMAL HEALTH INCORPORATED (2020)
11.1.4 BOEHRINGER INGELHEIM GROUP
TABLE 102 BOEHRINGER INGELHEIM GROUP: BUSINESS OVERVIEW
FIGURE 44 COMPANY SNAPSHOT: BOEHRINGER INGELHEIM GROUP (2020)
11.1.5 MERCK & CO., INC.
TABLE 103 MERCK & CO., INC.: BUSINESS OVERVIEW
FIGURE 45 COMPANY SNAPSHOT: MERCK & CO., INC. (2020)
11.1.6 ARCHER-DANIELS-MIDLAND COMPANY (ADM)
TABLE 104 ARCHER-DANIELS-MIDLAND COMPANY: BUSINESS OVERVIEW
FIGURE 46 COMPANY SNAPSHOT: ARCHER-DANIELS-MIDLAND COMPANY (2020)
11.1.7 BLUESTAR ADISSEO COMPANY
TABLE 105 BLUESTAR ADISSEO COMPANY: BUSINESS OVERVIEW
FIGURE 47 COMPANY SNAPSHOT: BLUESTAR ADISSEO COMPANY (2020)
11.1.8 ALLTECH CORPORATION
TABLE 106 ALLTECH CORPORATION: BUSINESS OVERVIEW
11.1.9 EVONIK INDUSTRIES AG
TABLE 107 EVONIK INDUSTRIES AG: BUSINESS OVERVIEW
FIGURE 48 COMPANY SNAPSHOT: EVONIK INDUSTRIES AG (2020)
11.1.10 VETOQUINOL S.A.
TABLE 108 VETOQUINOL S.A.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 BUPO ANIMAL HEALTH PTY LTD.
TABLE 109 BUPO ANIMAL HEALTH PTY LTD: BUSINESS OVERVIEW
11.2.2 NOVUS INTERNATIONAL, INC.
TABLE 110 NOVUS INTERNATIONAL, INC.: BUSINESS OVERVIEW
11.2.3 ASSOCIATED BRITISH FOODS PLC
TABLE 111 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
FIGURE 49 COMPANY SNAPSHOT: ASSOCIATED BRITISH FOODS PLC (2020)
11.2.4 ERBER AG
TABLE 112 ERBER AG: BUSINESS OVERVIEW
11.2.5 PHIBRO ANIMAL HEALTH CORPORATION
TABLE 113 PHIBRO ANIMAL HEALTH CORPORATION: BUSINESS OVERVIEW
FIGURE 50 COMPANY SNAPSHOT: PHIBRO ANIMAL HEALTH CORPORATION (2020)
11.2.6 KEMIN INDUSTRIES, INC.
TABLE 114 KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW
11.2.7 ZOETIS INC.
TABLE 115 ZOETIS INC.: BUSINESS OVERVIEW
FIGURE 51 COMPANY SNAPSHOT: ZOETIS INC. (2020)
11.2.8 NUTRECO N.V. (A WHOLLY-OWNED SUBSIDIARY OF SHV GROUP)
TABLE 116 NUTRECO N.V.: BUSINESS OVERVIEW
FIGURE 52 COMPANY SNAPSHOT: SHV GROUP (2020)
11.2.9 NOVOZYMES A/S
TABLE 117 NOVOZYMES A/S.: BUSINESS OVERVIEW
FIGURE 53 COMPANY SNAPSHOT: NOVOZYMES A/S (2020)
11.2.10 BASF SE
TABLE 118 BASF SE: BUSINESS OVERVIEW
FIGURE 54 COMPANY SNAPSHOT: BASF SE (2020)
11.2.11 LAND O’LAKES, INC.
11.2.12 CHR. HANSEN A/S
11.2.13 BIOMIN HOLDING GMBH
11.2.14 GUANGDONG VTR BIO-TECH CO., LTD.
11.2.15 LALLEMAND INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 237)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
